DCF substance-use services
Licensing information for substance abuse and mental health providers.
Visit DCF SAMH licensingFlorida news, policy resources and national perspectives for physicians and professionals working in addiction medicine.
Start with developments close to home, then explore clinical research, federal updates and selected global resources.
Reporting from WUSF's addiction and opioid coverage, including community responses, treatment and public policy.
Dates are the publishers' original publication dates. These specialty feeds update when the publishers add stories, so some articles may be several months old. Coverage is selective and may include national reporting.
Go directly to the agencies and official records for bills, rules, Medicaid alerts and substance-use services.
Licensing information for substance abuse and mental health providers.
Visit DCF SAMH licensingDepartment announcements and events. Check original notices for dates and program details.
Read DCF updatesRecent Florida Medicaid health care alerts, with links to the official notices.
Review Medicaid alertsSearch the Legislature's current and prior sessions. Confirm whether a bill is introduced, passed, signed or effective.
Search bills & statusSearch the Florida Administrative Code and Register for adopted rules and proposed changes.
Search official rule recordsState health announcements and public-health advisories.
Read health announcementsA news article or proposed bill is not a final legal requirement. Confirm the official text, status and effective date before making practice changes.
Automated updates from ASAM’s This Week in Addiction Medicine podcast and SAMHSA press announcements, kept separate from Florida reporting. Disaster-helpline bulletins are excluded to keep this stream focused.
Research highlights and perspectives for addiction medicine. The associated audio feed is a podcast, not a journal publication.
Read The ASAM WeeklyOfficial agency announcements, treatment and recovery resources.
Visit the newsroomSAMHSA notices and rulemaking records. Notices may be proposed, final or administrative.
Review SAMHSA noticesWHO invited manufacturers to submit selected medicines, including methadone, sublingual buprenorphine and naloxone, for evaluation through its Prequalification Programme. Read the original announcement for scope and context.
Read the WHO announcementSelected news item, not a live WHO feed. The date above is WHO’s publication date.
A focused route to WHO's substance-use work, guidance and international public-health resources.
Explore WHO resources